<ѻý>Antibody Slows Beta-Cell Loss Early in Type 1 Diabetesѻý> PROTECT trial may expand the biologic's use into a larger pool of recently diagnosed patients Oct 18, 2023
<ѻý>Clinical Challenges: Determining When to Stop MS Therapy as Patients Ageѻý> DISCOMS trial has provided data to guide decisions, now it's all about individualized discussions Oct 16, 2023
<ѻý>Cryoprecipitate, REBOA Flop for Improving Major Hemorrhage Outcomesѻý> The first randomized trials of both approaches failed Oct 13, 2023
<ѻý>Novel Nerve Ablation Procedure Explored for HFpEFѻý> Splanchnic nerve ablation for volume management passes a feasibility hurdle Oct 11, 2023
<ѻý>Copper-Boosting Agent Promising for Low Ejection Fraction Heart Failureѻý> Early-phase study analysis suggests potential for remodeling Oct 10, 2023
<ѻý>Modest Risks Come With Moving Fast on HF Drugs After Acute Eventѻý> STRONG-HF analysis details the impact Oct 10, 2023
<ѻý>Vagus Nerve Stimulation in Limbo for HFrEFѻý> Autonomic regulation therapy trial showed signal for benefit in terminated pivotal trial Oct 09, 2023
<ѻý>Biomarker-Based CardioMEMS Candidates Still Benefitѻý> GUIDE-HF trial analysis distinguishes "strata" with different levels of risk Oct 09, 2023
<ѻý>FDA Turns Down ATTR Cardiomyopathy Drugѻý> Decision cites insufficient evidence of clinical meaningfulness Oct 09, 2023
<ѻý>Novel Agent Promising as Add-On Epilepsy Treatmentѻý> Phase IIb trial shows benefit for the most common type of epileptic seizures Oct 09, 2023